Cytokinetics Inc (CYTK) stock
CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$51.65−1.52 (-2.86%)
Close on Nov 17, 2026Market cap $7.18BP/E –Yield –
Cytokinetics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Cytokinetics's price to book ratio was 0.0× on Oct 31, 2024, against 0.0× a year earlier. Over the last 5 years it ranged from 0.0× to 18.6×, with a median of 4.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Oct 31, 2024 | 0.0× | +0.0 |
| 2022 | Oct 31, 2022 | 0.0× | +0.0 |
| 2021 | Dec 31, 2021 | 0.0× | +0.0 |
| 2020 | Dec 31, 2020 | 0.0× | −18.6 |
| 2019 | Apr 30, 2019 | 18.6× | +12.0 |
| 2018 | Dec 31, 2018 | 6.6× | +3.6 |
| 2017 | Dec 29, 2017 | 3.0× | −2.8 |
| 2016 | Dec 30, 2016 | 5.8× | −0.2 |
| 2015 | Dec 31, 2015 | 6.0× | +2.0 |
| 2014 | Dec 31, 2014 | 4.0× | −0.8 |
| 2013 | Dec 31, 2013 | 4.8× | +3.7 |
| 2012 | Dec 31, 2012 | 1.2× | −0.1 |
| 2011 | Dec 30, 2011 | 1.2× | +0.0 |
| 2010 | Dec 31, 2010 | 1.2× | – |
See a number that looks wrong?